약학회지
YAKHAK HOEJI
ISSN 0377-9556 (PRINT)
ISSN 2383-9457 (ONLINE)

Table. 5.

Table. 5.

Generic Substitution system, How to prevent substitution of the South Korea, USA, Japan, France, United Ki

South Korea USA Japan France United Kingdom
Generic Substitution system Permissive Permissive Permissive Permissive nonpermissive

How to prevent substitution Indicate that the prescription cannot be substituted, with specifically indicate the clinical reason. Prescriber handwrites ‘DAW(Dispans as Written)’ or ‘Drug as Written’ or ‘Brand Necessary’ Marked in the box where generic Substitution is not possible Mention of explicit and justifiable reasons in the prescription -
Yakhak Hoeji 2021;65:183-9 https://doi.org/10.17480/psk.2021.65.3.183
© 2021 Yakhak Hoeji